Atlas Trials

Leukaemia, Lymphocytic, Chronic

11 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Leukaemia, Lymphocytic, Chronic

RecordFirmDate
A Phase I/II, Open-label Study of Ofatumumab Added to Chlorambucil in Previously Untreated Japanese Patients With Chronic Lymphocytic Leukemia (NCT01563055)GlaxoSmithKline2012-04-01
Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL) (NCT01520922)Novartis Pharmaceuticals2012-03-01
Phase IV Observational Study in Chronic Lymphocytic Leukemia (NCT01453062)GlaxoSmithKline2011-09-01
Ofatumumab Cardiac Repolarization (QTc) Study in Fludarabine-Refractory Chronic Lymphocytic Leukemia Subjects (NCT01110031)GlaxoSmithKline2010-05-13
Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy (NCT01039376)Novartis Pharmaceuticals2010-05-06
A Phase I/II, a Single Arm, Open-label Study of Ofatumumab (GSK1841157) in Patients With Previously Treated Chronic Lymphocytic Leukemia (NCT01077622)GlaxoSmithKline2009-09-01
Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia (NCT00824265)Novartis Pharmaceuticals2009-03-12
Efficacy and Safety of Ofatumumab Retreatment and Maintenance Treatment in Patients With B-cell Chronic Lymphocytic Leukemia (CLL) (NCT00802737)GlaxoSmithKline2009-01-01
Ofatumumab + Chlorambucil vs Chlorambucil Monotherapy in Previously Untreated Patients With Chronic Lymphocytic Leukemia (NCT00748189)Novartis Pharmaceuticals2008-12-22
Ofatumumab With Fludarabine and Cyclophosphamide in B-CLL Patients (NCT00410163)GlaxoSmithKline2007-01-01
HuMax-CD20 in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients Failing Fludarabine and Alemtuzumab (NCT00349349)GlaxoSmithKline2006-06-01

Track Leukaemia, Lymphocytic, Chronic automatically

Every clearance here is in the API, with alerts when new ones post.